Symrise Launches Cellexora MD, True Plant Exosomes from Upcycled Organic Italian Apples
After ingestible collagen and topical retinol, the next major focus for the skincare industry is exosomes. But not every ingredient carrying that name is the same thing. On March 31, 2026, global fragrance and ingredient company Symrise unveiled Cellexora MD at in-cosmetics Global in Paris, setting a standard for what “true exosomes” actually means in a formulated product.
Exosomes: The Messages Cells Send Each Other
Exosomes are nano-sized vesicles (tiny pouches) released by cells to send signals to other cells. They do not simply transfer ingredients; they enable biological communication. In the skin, this communication flows continuously between fibroblasts that produce collagen, keratinocytes that build the barrier, and macrophages that regulate immunity. With age and accumulated stress, these signals weaken.
Upcycled Organic Italian Apples as the Source
Cellexora MD is derived from byproducts of processing organic Italian apples. Symrise upcycles this material to extract plant-derived true exosomes. The INCI name is Maltodextrin, Malus domestica fruit vesicles. The ingredient is delivered as a white, odorless powder with a 100% natural origin index according to ISO 16128-2.
What Symrise emphasizes is the “true exosome” classification. Cellexora MD was manufactured and verified to meet the standards set by the ISEV, the leading international body in extracellular vesicle research. This distinguishes it from the many products on the market that label exosome-like fractions or cell-conditioned media as exosomes.
Three Cell Types, One Ingredient
Clinical data for Cellexora MD spans three distinct cell types. Keratinocytes form the outermost layers of skin and govern barrier function and moisture retention. Fibroblasts, located in the dermis, are responsible for producing collagen and elastin. Macrophages regulate skin immunity and manage inflammation. Ingredients that interact meaningfully with all three simultaneously are rare. Symrise’s claim is that this multi-target action allows Cellexora MD to address several hallmarks of skin aging at once.
30-Day Clinical Results: Wrinkle Length, Depth, Volume All Reduced
In a 30-day clinical study, participants using a product containing Cellexora MD showed statistically significant reductions in wrinkle length, depth, and volume. Improvements were also observed across collagen synthesis support, skin firmness, elasticity, and resilience against external stressors. The simultaneous changes across multiple outcome measures, rather than a single marker, is what the clinical team highlights.
A New Benchmark for Premium Skincare Ingredients
Cellexora MD launched officially at in-cosmetics Global Paris on March 31, 2026. A launch at a cosmetics ingredient trade show means finished-product brands can now formulate with this ingredient. Symrise positions Cellexora MD under the “healthspan” concept: extending not just longevity but the period during which skin cells function well. The goal is not simply to make skin look younger, but to preserve the functional lifespan of skin cells themselves.
Exosome skincare currently sits at the high end of the premium segment. Consumer awareness of exosome treatments has grown alongside injectable exosome procedures, but topical products formulated with verified true exosome ingredients remain rare. Cellexora MD’s launch represents an effort to set a clinical evidence baseline in this space.
Frequently Asked Questions
How is Cellexora MD different from other exosome ingredients? Cellexora MD contains true plant-derived exosomes that meet ISEV standards, not the exosome-like fractions or conditioned media often marketed under the same name. It is extracted from the byproducts of processing organic Italian apples via upcycling.
What did the 30-day clinical study show? After 30 days, wrinkle length, depth, and volume all decreased significantly. The study also confirmed support for collagen production, improvements in skin firmness and elasticity, and enhanced resilience against external stressors.
Which skin cell types does Cellexora MD interact with? The ingredient interacts with three cell types: keratinocytes, fibroblasts, and macrophages. This multi-target action across layers of the skin distinguishes it from single-pathway actives.